The global Patient Blood Management market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Patient blood management (PBM) is an evidence-based, multidisciplinary approach to optimizing the care of patients who might need transfusion.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The publisher report includes an overview of the development of the Patient Blood Management industry chain, the market status of Hospitals (Surgical Stage, Non-Surgical Stage), Clinics (Surgical Stage, Non-Surgical Stage), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Patient Blood Management.
Regionally, the report analyzes the Patient Blood Management markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Patient Blood Management market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Patient Blood Management market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Patient Blood Management industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Surgical Stage, Non-Surgical Stage).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Patient Blood Management market.
Regional Analysis: The report involves examining the Patient Blood Management market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Patient Blood Management market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Patient Blood Management:
Company Analysis: Report covers individual Patient Blood Management players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Patient Blood Management This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Patient Blood Management. It assesses the current state, advancements, and potential future developments in Patient Blood Management areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Patient Blood Management market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Patient Blood Management market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Surgical Stage
Non-Surgical Stage
麻豆原创 segment by Application
Hospitals
Clinics
Other Institutions
麻豆原创 segment by players, this report covers
SpecialityCare
Haemonetics Corporation
Baden-Wuerttemberg-Hessen
UPMC
B-BRAUN
Instrumentation Laboratory
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Patient Blood Management product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Patient Blood Management, with revenue, gross margin and global market share of Patient Blood Management from 2019 to 2024.
Chapter 3, the Patient Blood Management competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Patient Blood Management market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Patient Blood Management.
Chapter 13, to describe Patient Blood Management research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Patient Blood Management
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Patient Blood Management by Type
1.3.1 Overview: Global Patient Blood Management 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Patient Blood Management Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Surgical Stage
1.3.4 Non-Surgical Stage
1.4 Global Patient Blood Management 麻豆原创 by Application
1.4.1 Overview: Global Patient Blood Management 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Other Institutions
1.5 Global Patient Blood Management 麻豆原创 Size & Forecast
1.6 Global Patient Blood Management 麻豆原创 Size and Forecast by Region
1.6.1 Global Patient Blood Management 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Patient Blood Management 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Patient Blood Management 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Patient Blood Management 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Patient Blood Management 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Patient Blood Management 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Patient Blood Management 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 SpecialityCare
2.1.1 SpecialityCare Details
2.1.2 SpecialityCare Major Business
2.1.3 SpecialityCare Patient Blood Management Product and Solutions
2.1.4 SpecialityCare Patient Blood Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 SpecialityCare Recent Developments and Future Plans
2.2 Haemonetics Corporation
2.2.1 Haemonetics Corporation Details
2.2.2 Haemonetics Corporation Major Business
2.2.3 Haemonetics Corporation Patient Blood Management Product and Solutions
2.2.4 Haemonetics Corporation Patient Blood Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Haemonetics Corporation Recent Developments and Future Plans
2.3 Baden-Wuerttemberg-Hessen
2.3.1 Baden-Wuerttemberg-Hessen Details
2.3.2 Baden-Wuerttemberg-Hessen Major Business
2.3.3 Baden-Wuerttemberg-Hessen Patient Blood Management Product and Solutions
2.3.4 Baden-Wuerttemberg-Hessen Patient Blood Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Baden-Wuerttemberg-Hessen Recent Developments and Future Plans
2.4 UPMC
2.4.1 UPMC Details
2.4.2 UPMC Major Business
2.4.3 UPMC Patient Blood Management Product and Solutions
2.4.4 UPMC Patient Blood Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 UPMC Recent Developments and Future Plans
2.5 B-BRAUN
2.5.1 B-BRAUN Details
2.5.2 B-BRAUN Major Business
2.5.3 B-BRAUN Patient Blood Management Product and Solutions
2.5.4 B-BRAUN Patient Blood Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 B-BRAUN Recent Developments and Future Plans
2.6 Instrumentation Laboratory
2.6.1 Instrumentation Laboratory Details
2.6.2 Instrumentation Laboratory Major Business
2.6.3 Instrumentation Laboratory Patient Blood Management Product and Solutions
2.6.4 Instrumentation Laboratory Patient Blood Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Instrumentation Laboratory Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Patient Blood Management Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Patient Blood Management by Company Revenue
3.2.2 Top 3 Patient Blood Management Players 麻豆原创 Share in 2023
3.2.3 Top 6 Patient Blood Management Players 麻豆原创 Share in 2023
3.3 Patient Blood Management 麻豆原创: Overall Company Footprint Analysis
3.3.1 Patient Blood Management 麻豆原创: Region Footprint
3.3.2 Patient Blood Management 麻豆原创: Company Product Type Footprint
3.3.3 Patient Blood Management 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Patient Blood Management Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Patient Blood Management 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Patient Blood Management Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Patient Blood Management 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Patient Blood Management Consumption Value by Type (2019-2030)
6.2 North America Patient Blood Management Consumption Value by Application (2019-2030)
6.3 North America Patient Blood Management 麻豆原创 Size by Country
6.3.1 North America Patient Blood Management Consumption Value by Country (2019-2030)
6.3.2 United States Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Patient Blood Management Consumption Value by Type (2019-2030)
7.2 Europe Patient Blood Management Consumption Value by Application (2019-2030)
7.3 Europe Patient Blood Management 麻豆原创 Size by Country
7.3.1 Europe Patient Blood Management Consumption Value by Country (2019-2030)
7.3.2 Germany Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Patient Blood Management Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Patient Blood Management Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Patient Blood Management 麻豆原创 Size by Region
8.3.1 Asia-Pacific Patient Blood Management Consumption Value by Region (2019-2030)
8.3.2 China Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Patient Blood Management Consumption Value by Type (2019-2030)
9.2 South America Patient Blood Management Consumption Value by Application (2019-2030)
9.3 South America Patient Blood Management 麻豆原创 Size by Country
9.3.1 South America Patient Blood Management Consumption Value by Country (2019-2030)
9.3.2 Brazil Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Patient Blood Management Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Patient Blood Management Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Patient Blood Management 麻豆原创 Size by Country
10.3.1 Middle East & Africa Patient Blood Management Consumption Value by Country (2019-2030)
10.3.2 Turkey Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Patient Blood Management 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Patient Blood Management 麻豆原创 Drivers
11.2 Patient Blood Management 麻豆原创 Restraints
11.3 Patient Blood Management Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Patient Blood Management Industry Chain
12.2 Patient Blood Management Upstream Analysis
12.3 Patient Blood Management Midstream Analysis
12.4 Patient Blood Management Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
SpecialityCare
Haemonetics Corporation
Baden-Wuerttemberg-Hessen
UPMC
B-BRAUN
Instrumentation Laboratory
听
听
*If Applicable.
